Increasing evidence demonstrates the antitumour effects of 17-AAG in a variety of human malignancies, including suppression of cell growth and induction of apoptosis and cycle arrest in cholangiocarcinoma cells by inhibition of HSP90 function 28. This evidence concerns the gene HSP90AA1 and cholangiocarcinoma.